L’Oreal is set to acquire a majority stake in Medik8, a British skincare brand known for its vitamin A-focused products. This strategic move aims to bolster L’Oreal’s presence in the thriving skincare market. The deal, valuing Medik8 at approximately €1 billion, will see Inflexion, the current majority holder, retain a minority share.
Luxury skincare expansion: L’Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
You May Also Like
Posted in
All
Eye of Horus Slot
Posted by
Samreen Aslam
Posted in
All
Easter Island 2 slot demo Esparcimiento tragamonedas de balde
Posted by
Samreen Aslam